Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Betterbrand Review
A supplement company that did the thing we always ask for — it ran a real placebo-controlled trial. Then it led its marketing with the one endpoint that is not about lungs.
Betterbrand BetterLungs®
Real Trial, Softer Than MarketedCredit first: Betterbrand ran a randomised, triple-blind, placebo-controlled trial in 100 adults, registered as NCT07740746 with The Better Brand Inc. as sponsor. Blinding covered participants, investigators and outcomes assessors. Almost no supplement brand making these claims has anything comparable, and that should be said before anything else.
The range is built on mullein, chlorophyll, NAC, sea moss and elderberry. Checked on 8 August 2026, most BetterLungs products were $34.95 for a 30-day supply, $31.45 each in threes, or $27.95 on subscription. HSA/FSA eligible. Founded by Dr Chris Jackson, PharmD, a US Army veteran and former combat medic.
Now the part the press release does not lead with. The only outcome reported as significant against placebo was fatigue, on the Fatigue Severity Scale. Every respiratory figure — 74% found it easier to clear mucus, and so on — is a percentage of the treated group agreeing with a statement, with no placebo comparison given. There is no spirometry anywhere in the protocol. And the trial was first posted to the registry on 3 August 2026, eleven months after it finished.
Affiliate disclosure: GLP1Drugs.org earns a commission if you buy through the links on this page. We pulled the trial record from ClinicalTrials.gov rather than relying on the press release, and read the refund policy against the FAQ. Verified 8 August 2026.
Visit BetterbrandOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
100
Participants In A Real RCT
1
Endpoint Significant Vs Placebo
0
Objective Lung Measurements
$27.95
Per Month On Subscription
What The Trial Does And Does Not Show
Six things to hold separate before you read another percentage.
The Trial Is Real And Registered
NCT07740746 on ClinicalTrials.gov: randomised, triple-blind, placebo-controlled, 100 adults, 60 days, sponsored by The Better Brand Inc. Most supplement brands never get this far, and it deserves saying plainly
But Only Fatigue Beat Placebo
The one outcome reported as statistically significant against the placebo arm was fatigue, on the validated Fatigue Severity Scale. That is the endpoint the press release leads with — and it is a secondary outcome
The Respiratory Numbers Have No Control Arm
'74% found it easier to clear chest mucus' is a proportion of the treated group agreeing with a statement. No placebo comparison is given for any respiratory figure, and placebo groups improve substantially in symptom trials
Every Endpoint Was Self-Reported
Data came from symptom questionnaires and the Fatigue Severity Scale. There is no spirometry, no FEV1, no imaging and no sputum measurement anywhere in the protocol — for a product sold as lung support
Registered After It Finished
The trial completed 30 August 2025. It was first posted to ClinicalTrials.gov on 3 August 2026 — roughly eleven months later, and about four months after the March 2026 press release announcing the results
Results Are Not Posted
The registry record carries no results. What is public is the sponsor's own summary and the testing lab's page, not a peer-reviewed publication or registry data you can independently check
Which Claims Have A Placebo Arm Behind Them
The distinction that decides what this trial is worth. A percentage without a comparison group is not a result.
| Claim | How it was measured | Compared to placebo? |
|---|---|---|
| Reduced fatigue | Fatigue Severity Scale, a validated instrument, at Day 20 and Day 60 | Yes — reported significant |
| Easier to clear chest mucus | 74% of the treated group agreed with the statement at Day 60 | No figure given |
| Less mucus overall | 74% of the treated group agreed with the statement at Day 60 | No figure given |
| Less breathlessness | 74% agreed for daily activities; a separate figure for physical activity | No figure given |
| Any lung function measure | Not measured — no spirometry, FEV1, imaging or sputum in the protocol | Not applicable |
Why the middle rows matter: in trials of subjective respiratory symptoms, the placebo group typically also improves a great deal. Without the placebo percentage next to it, '74% agreed' cannot tell you whether the product did anything. This is a supplement, not a treatment — if breathlessness is what brought you here, read our side effects guide and our provider rankings, and see a clinician about the symptom itself.
Pros & Cons
Pros
- ✓A genuinely registered randomised, triple-blind, placebo-controlled trial (NCT07740746) with 100 participants — a real bar that most supplement brands never clear
- ✓Blinding covered participants, investigators and outcomes assessors, and there was a matched placebo arm
- ✓The reduction in fatigue on the Fatigue Severity Scale is reported as significant against placebo at both Day 20 and Day 60
- ✓Founded by Dr Chris Jackson, PharmD, a US Army veteran and former combat medic, with a stated personal reason for building the product
- ✓Products are described as made in the USA in a GMP-certified facility and third-party tested by Eurofins Scientific
- ✓Trustpilot sits at 4.3 across 65 reviews — modest volume, but a positive record
- ✓The required FDA disclaimer is present in the site footer on every page we checked
- ✓Subscription is a real 20% saving, taking a $34.95 bottle to $27.95, and the cancellation policy says you can change or cancel at any time
- ✓HSA/FSA eligible at checkout
Cons
- ✕The only placebo-controlled significant result is fatigue; every respiratory claim is an uncontrolled 'percentage who agreed' with no placebo arm shown
- ✕No objective lung measurement of any kind — no spirometry, no FEV1 — in a product marketed for airways and mucus
- ✕The trial was registered roughly eleven months after it completed and months after its results were publicised, so the endpoints were on record only after the data existed
- ✕No results are posted to the registry, and we found no peer-reviewed publication
- ✕The FAQ promises a '365-day money-back guarantee on all products', but the refund policy states 'Each customer gets only one return per lifetime'
- ✕The refund policy also says sale and promotional items cannot be returned, which the 'all products' phrasing does not suggest
- ✕That same policy anticipates customers who 'claim they were unaware of the subscription' — the company's own words for a recurring-billing problem
- ✕Product names such as 'Allergy Relief Protocol' and 'Quit Smoking Support Bundle' read as disease claims, while the footer states the company 'makes no health or medical claims'
- ✕The Sea Moss Gummies contain no iodine figure and no thyroid caution anywhere on the product page — sea moss concentrates iodine
- ✕Four of the eight landing pages supplied to affiliates are dead or misdirect, including Sea Moss Gummies, which silently redirects to a mullein product
- ✕The product page runs a countdown timer telling you how long you have to order 'today', which resets
- ✕We could not find a public certificate of analysis to check the Eurofins testing claim against
Our Verdict
3.1 / 5 — a supplement company that ran a real placebo-controlled trial and then marketed the one result that was not about lungs.
We spend a lot of these reviews asking why a brand has no controlled evidence, so it is only fair to start where Betterbrand is genuinely ahead. It ran a randomised, triple-blind, placebo-controlled trial in 100 adults, with blinding across participants, investigators and assessors, and it registered the study on ClinicalTrials.gov as NCT07740746. The founder is a PharmD and former Army combat medic with a stated personal reason for building the product. The company claims GMP manufacturing and Eurofins testing, the FDA disclaimer is present on every page we checked, Trustpilot sits at 4.3, and the subscription discount is a real 20% rather than a gesture. None of that is nothing.
What pulls the score down is the distance between the trial and the marketing. The only endpoint reported as significant against placebo was fatigue — a secondary outcome, on a product named for your lungs. The respiratory claims are all reported as bare percentages of the treated group agreeing with a statement, with no placebo figure alongside, which is the one number that would make them meaningful. Nothing objective was measured at all: no spirometry, no FEV1. And the registry entry went up eleven months after the study finished and four months after the results were announced, which is the wrong order for endpoints to be fixed in.
Then there are the commercial details. The FAQ advertises a 365-day money-back guarantee on all products; the refund policy permits one return per customer per lifetime and excludes sale items. The same policy has a procedure for customers who did not realise they had subscribed. Four of the eight landing pages the affiliate programme hands out are dead or redirect elsewhere, with Sea Moss Gummies quietly landing you on a mullein product instead. And the sea moss line states no iodine content and gives no thyroid caution, which is a genuine gap for readers of this site in particular. Buy it, if you buy it, as a herbal product for mild and already-explained congestion — not as a substitute for finding out why you are short of breath.
Visit BetterbrandFrequently Asked Questions
Is BetterLungs actually clinically studied, or is that marketing?
It is genuinely studied, and we want to give that its full weight before adding the caveats. Betterbrand ran a randomised, triple-blind, placebo-controlled trial of BetterLungs Mullein + Chlorophyll in 100 adults over 60 days, conducted by Citruslabs and registered on ClinicalTrials.gov as NCT07740746 with The Better Brand Inc. as sponsor. Blinding covered participants, investigators and outcomes assessors, and there was a matched placebo. That is a real design, and the overwhelming majority of supplement brands making comparable claims have nothing like it. The caveats are about what the trial measured and when it was registered. Every outcome was self-reported: participants filled in symptom questionnaires and the Fatigue Severity Scale at Baseline, Day 20, Day 40 and Day 60. There is no spirometry, no FEV1, no imaging and no sputum measurement anywhere in the protocol, which is a notable absence in a product sold for your airways. The registry record was first posted on 3 August 2026, while the study completed on 30 August 2025 — about eleven months earlier, and roughly four months after the company publicised the results in March 2026. Prospective registration exists precisely so that endpoints are fixed before anyone sees the data, and that did not happen here. No results are posted to the registry.
So what did the trial actually show?
One thing clearly, and the rest ambiguously. The single outcome reported as statistically significant against the placebo group was fatigue, measured on the Fatigue Severity Scale, at Day 20 and again at Day 60. That is a validated instrument and a real finding — but note that on the registry, energy is a secondary outcome, while the primary outcomes were mucus clearance and respiratory symptoms. The respiratory results are presented very differently. The testing lab's page reports figures such as 74% of participants agreeing they found it easier to clear chest mucus, 74% agreeing they had less mucus, and 74% agreeing they had less breathlessness during daily activities. Every one of those is a proportion of the treated group agreeing with a statement. No placebo figure is given alongside any of them. This matters more than it might sound: in trials of subjective respiratory symptoms, placebo groups routinely report large improvements, so a raw 74% in the treated arm tells you almost nothing on its own. The honest summary is that a supplement marketed for lungs produced its clearest placebo-controlled result on tiredness, and its lung claims are the ones without a control comparison attached.
Does this have anything to do with GLP-1 medication?
No, and you should not read it as related. Betterbrand does not prescribe, does not compound and does not sell anything that affects GLP-1 receptors. It is a herbal supplement company selling mullein, chlorophyll, NAC, sea moss, elderberry and mushroom products, and it appears here because it markets to an overlapping audience, not because it belongs in the same category. If you are looking for treatment, our provider rankings are the relevant page. There is one genuine point of contact worth knowing, and it runs the other way. The trial enrolled people reporting breathlessness, chest mucus and low energy — a symptom cluster very common in people carrying excess weight, where the usual causes are obstructive sleep apnoea, deconditioning, asthma or a cardiac problem. Those are diagnosable and treatable things, and one of them now has a licensed medication: tirzepatide is FDA-approved for moderate-to-severe obstructive sleep apnoea in adults with obesity. New or worsening breathlessness is a reason to be examined, not a reason to buy a supplement. Treating it with mullein tea and finding the symptom eases somewhat is a way to delay a diagnosis that would actually change your care.
What about the sea moss products and my thyroid?
This is the safety point we would most want a GLP-1 audience to read. Sea moss is a red seaweed, and seaweeds concentrate iodine from seawater — often heavily, and with wide variation between batches and species. The tolerable upper intake level for iodine in adults is 1,100 micrograms per day, and it is entirely possible for seaweed products to approach or exceed that in a serving. Too much iodine is not benign: it can suppress thyroid hormone production through the Wolff-Chaikoff effect, or in people with nodules or latent Graves' disease it can trigger the opposite problem and drive hormone production up, the Jod-Basedow effect. People with Hashimoto's are particularly sensitive. We checked Betterbrand's Sea Moss Gummies page on 8 August 2026 and found no iodine quantity stated and no thyroid caution of any kind. That is a real gap, and it is one you should care about specifically if you take a GLP-1: semaglutide and tirzepatide both carry a boxed warning about thyroid C-cell tumours and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2. That does not mean sea moss causes those problems — it does not. It means this is an audience already being monitored around the thyroid, taking an unlabelled iodine load for no established benefit. If you have any thyroid condition, ask your clinician first, and ask Betterbrand for the iodine content in writing.
What does it cost, and is the subscription safe to start?
Checked on 8 August 2026, most of the BetterLungs range was $34.95 for a 30-day supply. Three bottles were $94.35, working out at $31.45 each, and six were $178.20. Subscribe and save cuts a single bottle to $27.95, a genuine 20% reduction rather than a token one. Bundles ran higher: the Quit Smoking Support Bundle at $79.95, the Lung Detox Protocol at $89.95, the Clear Mucus Protocol and Seasonal Wellness Box at $99.95, and BetterMushrooms at $39.95. Checkout is HSA/FSA eligible. On the subscription itself, the stated cancellation policy is reasonable — you can modify, pause or cancel at any time through your account, and order confirmation emails link back to it. But read the refund policy alongside it, because it contains a sentence the company presumably did not intend as a warning: it explains what to do 'if the order has already shipped and a customer claims they were unaware of the subscription', advising that they refuse delivery to avoid a return shipping fee. A business writes that sentence because it happens often enough to need a procedure. If you subscribe, note the renewal date somewhere you will see it.
Is the 365-day money-back guarantee real?
It is real but much narrower than the phrasing suggests, and the two documents on the site do not agree. The FAQ states that Betterbrand 'offers a 365-day money-back guarantee on all products — the longest guarantee in the supplement industry', and that if you are not satisfied for any reason within a year you can request a full refund. The refund policy, which is the binding document, adds limits that change the picture. It states: 'Each customer gets only one return per lifetime, once consumed no further returns will be accepted.' It also says certain items cannot be returned at all, specifically naming promotional and sale items — so 'all products' is not accurate if you bought during a discount, which is how most supplement purchases happen. Returns must be requested by emailing hello@betterbrandhealth.com, items sent back without prior approval are refused, and refunds are only processed after the return is received and inspected. None of that is unusual on its own. The problem is the gap between a marketing promise of a year-long, all-products, any-reason guarantee and a policy that permits one return ever and excludes discounted goods. Read the second document, not the first.
Are the ingredients backed by anything?
Unevenly, and one of them has a regulatory quirk worth knowing. NAC — N-acetyl cysteine, in the BetterLungs capsules — has the strongest evidence base of anything in the range: it is a genuine mucolytic used in hospital medicine, and it has been studied in chronic bronchitis and COPD. Its oddity is regulatory. The FDA's position is that NAC is excluded from the definition of a dietary supplement, because it was approved as a drug before it was marketed as a supplement. Since a final guidance in August 2022 the agency has said it intends to exercise enforcement discretion for NAC-containing supplements that are otherwise lawful, so these products are sold under a stated policy of non-enforcement rather than clear eligibility. Mullein is the brand's signature ingredient and has a long traditional history for coughs and congestion, but the human clinical literature is thin — the site's own FAQ concedes that clinical trials on it 'are still limited', which is a fair thing to admit. Chlorophyll for respiratory benefit is not well supported. Sea moss is a nutrient source rather than a proven therapy, and carries the iodine issue described above. Betterbrand says everything is made in the USA in a GMP-certified facility and third-party tested by Eurofins Scientific; we could not locate a public certificate of analysis to check that against, so we can report the claim but not verify it.
Should I be concerned about how the products are named?
It is the part of the operation we would most expect a regulator to look at. A dietary supplement may make structure-function claims, such as supporting respiratory health, but it may not claim to treat, prevent or mitigate a disease — that makes it an unapproved drug in the FDA's eyes. Several product names sit uncomfortably close to that line. 'Allergy Relief Protocol' names a medical condition and promises relief from it. 'Quit Smoking Support Bundle', described as helping to 'manage smoking cravings naturally', is adjacent to smoking-cessation aids, a category the FDA regulates as drugs. 'Lung Detox Protocol' and 'Clear Mucus Protocol' are milder but pointed in the same direction. Set against that, the footer disclaimer is unusual in its own way. Alongside the standard wording, it says the products are not designed for 'altering any bodily structure/function' and that 'Betterbrand Health makes no health or medical claims for the product' — which disclaims the structure-function claims a supplement is actually allowed to make, and contradicts the pages above it. We found no FDA warning letter to Betterbrand, and we are not predicting one. But naming and disclaimer are pulling against each other here, and the disclaimer is the part almost nobody reads.
Who is it for, and who should skip it?
It suits someone with mild, already-explained chest congestion or a smoker's cough who has had the underlying cause looked at, wants to try a herbal product, and is buying with clear eyes about what the trial did and did not establish. On that basis $27.95 to $34.95 a month is not outrageous, the company is more evidence-minded than most of its competitors, and the fatigue result is at least a real placebo-controlled finding. Skip it if your breathlessness is new, worsening, or waking you at night — that needs a clinician, not a tincture, and in people with obesity it frequently turns out to be sleep apnoea. Skip the sea moss products entirely if you have any thyroid condition or are being monitored for one, at least until you have the iodine content in writing. And be careful about buying on the strength of the guarantee: the promise is a year and all products, the policy is one return per lifetime and nothing bought on discount.
Find Out Why You Are Short Of Breath First
Breathlessness in people carrying excess weight is often sleep apnoea, and that has a licensed treatment. A herbal tincture is a reasonable thing to add afterwards, not instead.
Visit BetterbrandCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Amazon One Medical
Brand-Name, No CompoundingFDA-approved Wegovy, Zepbound and Foundayo from $149/month cash, $25 with insurance and $50/month for eligible Medicare members — the first mainstream route to approved medication at prices that compete with compounded. We earn no commission from it
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →Henry Meds
Top RatedWell-established telehealth platform with fast physician reviews and competitive pricing
Read Review →PlushCare
Insurance AcceptedMajor telehealth platform with brand-name FDA-approved GLP-1s, insurance support, and 1M+ members treated
Read Review →BeyondMD
Top RatedBoard-certified physician-led care with comprehensive medical oversight
Read Review →CoreAge Rx
#1 RecommendedFlat-rate pricing for compounded semaglutide and tirzepatide with NABP-verified pharmacies
Read Review →Medical Disclaimer: This page is informational and is not medical advice. These are dietary supplements, not medicines; they are not intended to diagnose, treat, cure or prevent any disease and are not a substitute for prescribed treatment. New, worsening or persistent breathlessness, chest pain, coughing up blood or unexplained weight loss require prompt medical assessment rather than a supplement. In people with obesity, breathlessness and fatigue are commonly caused by obstructive sleep apnoea, deconditioning, asthma or cardiac disease, all of which are diagnosable and treatable. Sea moss and other seaweeds concentrate iodine, and excess iodine can cause both underactive and overactive thyroid function; anyone with a thyroid condition, or being monitored for one, should seek advice before taking sea moss products. Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2. Tell your clinician about any supplement you take alongside prescribed medication.
Date reviewed: 8 August 2026. Trial details are from the ClinicalTrials.gov record NCT07740746, 'A Study to Evaluate the Effects of a Supplement on Mucus Clearance and Respiratory Symptoms', sponsor The Better Brand Inc., listing 100 actual enrolment, randomised allocation, triple masking of participants, investigators and outcomes assessors, a BetterLungs Mullein experimental arm and a placebo comparator, start 22 April 2025, completion 30 August 2025, first posted 3 August 2026, with no results posted and Citruslabs as the listed location. Primary outcomes are recorded as change in mucus clearance and change in respiratory symptoms; energy levels, shortness of breath and general well-being are secondary. Outcome figures including the 74% agreement rates and the reported significant reduction in fatigue on the Fatigue Severity Scale at Day 20 and Day 60 are from the Citruslabs results page. Prices, the 20% subscription discount, HSA/FSA eligibility and product names were taken from trybetterbrand.com on the date above and may change. The quoted refund terms 'Each customer gets only one return per lifetime, once consumed no further returns will be accepted' and the guidance regarding customers who 'claim they were unaware of the subscription' are from the site's refund policy; the '365-day money-back guarantee on all products' wording is from its FAQ. The Sea Moss Gummies product page carried no iodine quantity or thyroid caution when checked. Trustpilot showed 4.3 across 65 reviews. We found no FDA warning letter issued to Betterbrand, and no BBB profile. A Walgreens site search for 'betterlungs' returned one item, a different brand's product; CVS and Amazon searches were blocked to us, so we could not verify retail availability either way. We could not locate a public certificate of analysis for the Eurofins testing claim. FDA's position on NAC and its August 2022 enforcement discretion guidance are as published by the agency.
Affiliate Disclosure: This site may receive compensation from affiliate partners. This does not influence our editorial content or review ratings.